Treatment-induced p53 heterogeneity within Ras mutant tumor tissues would allow cells with extensive genomic insults (high dp53 levels) to directly induce the upregulation of JAK/STAT ligands, which instructs nearby less-damaged (low dp53) RasV12 cells to overproliferate and reestablish the tumor following treatment. This evidence concerns the gene TP53 and neoplasm.